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Objectives: To determine whether chronic conditions and patient factors, such as risk perception 
and decision-making preferences, are associated with complementary medicine and alternative 
practitioner use in a representative longitudinal population cohort.
Participants and setting: Analysis of data from Stage 2 of the North West Adelaide Health 
Study of 3161 adults who attended a study clinic visit in 2004–2006. The main outcome 
measures were the medications brought by participants to the study clinic visit, chronic health 
conditions, attitudes to risk, levels of satisfaction with conventional medicine, and preferred 
decision-making style.
Results: At least one oral complementary medicine was used by 27.9% of participants, and 7.3% 
were visiting alternative practitioners (naturopath, osteopath). Oral complementary medicine use 
was significantly associated with arthritis, osteoporosis, and mental health conditions, but not with 
other chronic conditions. Any pattern of complementary medicine use was generally significantly 
associated with female gender, age at least 45 years, patient-driven decision-making preferences 
(odds ratio [OR] 1.38, 95% confidence interval [CI]: 1.08–1.77), and frequent general practitioner 
visits (.five per year; OR 3.62, 95% CI: 2.13–6.17). Alternative practitioner visitors were younger, 
with higher levels of education (diploma/trade [OR 1.88, 95% CI: 1.28–2.76], bachelor’s degree 
[OR 1.77, 95% CI: 1.11–2.82], income . $80,000 (OR 2.28, 95% CI: 1.26–4.11), female gender 
(OR 3.15, 95% CI: 2.19–4.52), joint pain not diagnosed as arthritis (OR 1.68, 95% CI: 1.17–2.41), 
moderate to severe depressive symptoms (OR 2.15, 95% CI: 1.04–4.46), and risk-taking behavior 
(3.26, 1.80–5.92), or low-to-moderate risk aversion (OR 2.08, 95% CI: 1.26–4.11).
Conclusion: Although there is widespread use of complementary medicines in the Australian 
community, there are differing patterns of use between those using oral complementary medi-
cines and those using alternative practitioners.
Keywords: complementary medicine, chronic disease, risk attitudes, population study
Introduction
Population studies indicate that the use of complementary medicine has become 
increasingly popular in Australia and in other Western countries. There appears to be 
no consensus on the definition of “complementary medicine” therapy. Complementary 
medicine covers a range of oral supplements, herbal medicines, vitamins, and   minerals. 
Some studies have also included chiropractic therapies, osteopathy, nutritional thera-
pies, exercise-based therapies, aromatherapy, massage, and acupuncture. The National 
Institute for Complementary Medicine in Australia has adopted, with revisions, the 
four domains of complementary medicine articulated by the US National Center for 
Complementary and Alternative Medicine (www.nicm.edu.au). These four domains 
are mind-body medicine, biologically based practices, manipulative and body-based Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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Table 1 Prevalence of oral complementary medicine use by type
Complementary medicine type % (n)
Multivitamin 13.3 (420) Black cohosh 0.6 (19)
Fish oil 6.0 (188) Magnesium 0.6 (20)
glucosamine/shark 
cartilage
5.7 (179) Probiotics 0.5 (15)
Vitamin C 3.0 (95) saw Palmetto 0.4 (13)
Other herbal  2.8 (89) st. John’s wort 0.4 (12)
Vitamin B 2.7 (86) Amino acid 0.4 (12)
Vitamin E 2.0 (62) Flaxseed oil 0.3 (8)
ginkgo biloba 1.6 (50) Coenzyme Q10 0.3 (11)
Evening primrose oil 1.5 (48) Celery 0.2 (6)
garlic  1.4 (44) Echinacea 0.2 (7)
Zinc 1.1 (36) ginseng 0.2 (5)
Mineral 0.8 (26) Emu oil 0.1 (3)
Cod liver oil 0.7 (22)
  practices, and energy systems. In addition, whole medical 
systems are included which can cut across domains. These 
include homeopathy,   naturopathy, and traditional Chinese 
medicine. This study focuses on biologically based practices 
(such as herbs, foods, and vitamins), including what the 
Australian Therapeutic Goods Administration defines and 
regulates as complementary medicines, and whole systems 
(such as naturopathy).
Despite the popularity of complementary medicine,1–3 pre-
vious Australian studies1,4–6 have not assessed complementary 
medicine use in relation to chronic conditions and risk factors, 
or identified preferences or risk perceptions of complemen-
tary medicine users. International surveys often find that oral 
complementary medicine use is more prevalent among younger 
women from higher socioeconomic backgrounds.2,3 However, 
one US study suggested that risk attitude is as strong a predictor 
of visits to alternative practitioners as are sociodemographic 
factors.7 This study also showed that attitudes to risk differed 
between people who used oral complementary medicine and 
those who attended complementary practitioners such as natur-
opaths. The latter group perceive themselves as risk-takers, 
compared with self-administering complementary medicine 
users who rated themselves not differently from the general 
population,7 but we are not aware that this research has been 
replicated. The relationship between dissatisfaction or distrust 
with orthodox medicine and complementary medicine use 
also remains unclear.8–10 An understanding of the relationship 
between complementary medicine use and preferences for 
autonomy in decision-making about care is also limited by a 
lack of representative data, but studies in selected populations 
suggest no relationship.8,11
The aim of this population-based study was to assess the 
prevalence of oral complementary medicine use and the demo-
graphics of complementary medicine users; the associations of 
oral complementary medicine use and complementary practi-
tioner visits with lifestyle risk factors and chronic medical con-
ditions; and whether complementary medicine use is related 
to attitude to risk and decision-making. We also assessed the 
relationship between oral complementary medicine use and 
complementary practitioner visits and attitudes towards risk, 
participatory decision-making style, and satisfaction with 
conventional medicine, because this has rarely been described 
previously in a large representative population sample.
Methods
sample population and study method
Participants of the North West Adelaide Health Study 
(NWAHS) were recruited from households randomly selected 
from the electronic telephone directory in 2000–2002. 
At follow-up of the NWAHS cohort in 2004–2005 (response 
rate 81.0%), clinical assessment and medication data were 
available for 3161 individuals. The methods of the NWAHS12 
and the validity of these methods of selection to achieve 
an unbiased sample13 have been described previously. In 
particular, there were no major differences between study 
participants and the comparison population in terms of 
health indicators or lifestyle behaviors.14 The study was 
approved by the Institutional Ethics Committee of the North 
West Adelaide Health Service, and all subjects gave written 
informed consent.
Respondents completed telephone and written ques-
tionnaires, and underwent clinical assessment including 
spirometry, measurement of blood pressure, weight, height, 
and fasting blood tests for plasma glucose and lipids. 
Questionnaires collected information on health behaviors 
(smoking, recreational physical activity, and alcohol use), 
doctor-diagnosed conditions, including rheumatoid arthritis, 
osteoarthritis, osteoporosis, diabetes, chronic obstructive pul-
monary disease, asthma, cardiovascular disease   (myocardial 
infarction, angina, stroke) and mental health conditions, 
symptoms of joint pain (in foot, knee, hip, hand, and/or 
shoulder), depression, health service utilization (visits in 
the last 12 months to primary care providers, psychologists, 
chiropractors, and other therapists, including osteopaths and 
naturopaths), and demographics.
Current oral complementary medicine use was identified 
by asking participants to bring all medications, including 
prescription medications that they were currently using, to 
the clinic visit (Table 1). Information on duration of use was 
not obtained. Vitamin D, calcium, and iron supplements were 
not considered to be oral complementary medicines when Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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they had been prescribed by a medical practitioner for an 
underlying medical condition.
Chronic conditions
Undiagnosed joint pain was defined as pain in at least one site 
(foot, knee, hip, hand, shoulder) that had not been previously 
classified by a doctor as osteoarthritis, rheumatoid arthritis, 
or other arthritis. Diabetes, asthma, and chronic obstruc-
tive pulmonary disease were defined by clinic measure-
ments or report of doctor-diagnosis, as has been described 
previously.12 Asthma was defined as current self-reported 
physician-diagnosed asthma or demonstration of a significant 
bronchodilator response of at least 12% of baseline forced 
expiratory volume in one second (FEV1) in the absence of a 
doctor-diagnosis of asthma.15,16 Participants with persistent 
airways obstruction, ie, postbronchodilator FEV1/forced vital 
capacity (FVC) ratio less than 0.7017 were also identified as 
having chronic obstructive pulmonary disease. Diabetes was 
defined as fasting blood glucose $7.0 mmol/L, self-reported 
physician diagnosis of diabetes, or treatment for diabetes. 
Depression was assessed with the Center for Epidemiologic 
Studies Depression Scale (CES-D), a 20-item questionnaire 
which covers the major components of depressive symp-
tomatology.18 CES-D scores range from 0 to 60, with scores 
16–26 considered indicative of mild depression, and scores 
of $27 indicative of major depression.19,20
Lifestyle variables
Body mass index (weight/height squared, in kg/m2) was cat-
egorized according to international criteria, ie, underweight/
normal #24.9, overweight 25.0–29.9, and obesity: $30.0.21 
Recreational physical activity was calculated as the number 
of times activity was undertaken by average time per session 
by (self-perceived) intensity22 and categorized as sedentary, 
low, moderate, and high exercise. Risk level of alcohol use 
(intermediate- to very high-risk) was classified as at least an 
average daily intake of four drinks (or 9–12 drinks in any 
day) in females and an average daily intake of 5–8 drinks 
(or occasional excess) in males.23
risk aversion, decision-making 
preferences, and satisfaction with care
An individual’s level of risk aversion was assessed (n = 2342) 
by using questions based on data obtained from a National 
Patient Safety Foundation survey in America.24 Risk aversion 
was assessed using the following questions: “On a scale of 
1 to 7, with 7 = very risky and 1 = not risky at all, how risky 
do you think the following behaviors are:
a.  Not testing smoke detectors regularly if they are in your 
home?
b.  Leaving appliances plugged in while you are away for 
an extended period of time?
c.  Smoking tobacco or cigarettes?
d.  Using foodstuffs after use-by date?
e.  Driving a car after consuming alcohol?
f.  Not carrying medical identification when you have a medi-
cal condition such as allergies, diabetes, or epilepsy?”
The scoring system was modified (to take into account 
missing data on some items) so that the average of the 
responses to these six questions was used; 6.66–7 was coded 
as highly risk-averse, 5–6.65 was coded as moderately risk-
averse, and ,5 were considered to be risk-takers.25
Patient satisfaction with conventional medicine was 
assessed by the following question: “Thinking about your 
most recent experience with a doctor or hospital, how 
  satisfied were you with the health care you received?” (very 
satisfied, somewhat satisfied, somewhat dissatisfied, very 
  dissatisfied). Patient preferred decision-making was assessed 
by the response to: “In what way do you prefer to make 
  decisions regarding your health care or medical treatments?” 
(“I prefer the final decision to be made:
By me (on basis of my own knowledge of risks/benefits or 
by strongly considering the doctor’s opinion)
On an equal basis with the doctor
By the doctor (on the basis of their knowledge of risks/
benefits or with my opinion considered)”.
statistical analysis
Data were weighted to census data by region, age group, 
  gender, and probability of selection in the household, to 
provide population-representative estimates. Data were 
analyzed using SPSS (Version 15.0, SPSS Inc, Chicago, IL). 
Chi-square tests determined differences in proportions 
of those using complementary medicines in relation to 
  sociodemographic, chronic disease, and chronic disease risk 
factors. All variables (chronic conditions, risk factors, health 
service use, individual factors such as risk aversion) were 
then entered into multivariable   logistic regression analyses 
to develop separate models for the factors associated with 
oral complementary medicine use and alternative practi-
tioner visits, adjusted for covariates including age, gender, 
smoking status, body mass index, and socioeconomic status 
  (education, income, employment status). Variables were 
progressively removed from models and the effect on associa-
tions and the model-fit were examined. Results are expressed 
as odds ratios (OR) with 95% confidence intervals (CI).Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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Table 2 Reasons for oral complementary medicine use identified 
by participants
Reason % n
general health and well-being  53.3 862
Muscles, bones, and joints 24.0 384
nerves/stress/brain health 3.9 62
Premenstrual symptoms/menopause 3.6 57
Lung/sinuses 3.4 55
skin 3.3 53
Circulation/cardiovascular disease 3.1 49
gastrointestinal system and liver 0.7 11
Eye health  0.6 10
Prostate 0.5 8
Bladder/kidneys 0.2 3
Other 3.4 54
Total 100.0 1608
Results
The prevalence of oral complementary medicine use by type 
is listed in Table 1. Overall 883 (27.9%) of study   participants 
were currently taking one or more complementary medicines. 
The prevalence of subjects taking 1–2, 3–4, and $5 comple-
mentary medicines was 22.4% (n = 709), 4.5% (n = 143), 
and 1.0% (n = 31), respectively. Approximately half of all 
oral complementary medicines were reported to be taken 
for general health and well-being and one quarter were used 
for muscle, bone, and joint health (Table 2). At univariate 
level, oral complementary medicine use was associated with 
female gender, older age, and not being in the paid work-
force, but not with other socioeconomic factors (education or 
household income). Only a limited range of chronic medical 
conditions were associated with increased oral complemen-
tary medicine use, including diagnosed arthritis (as well 
as symptoms of joint pain/stiffness), osteoporosis, chronic 
obstructive pulmonary disease, and mental health conditions 
(Table 3). Complementary practitioner visits (naturopaths, 
osteopaths) were reported by 7.3% (n = 230), and were 
associated with differing sociodemographics compared with 
oral complementary medicine users, including younger age, 
higher levels of education, and being in the paid workforce 
(Table 3). These differences are reflected in the significantly 
increased visits to complementary practitioners in those 
without risk factors or chronic disease. Table 4 shows that 
health care use in the previous 12 months was significantly 
associated with oral complementary medicine use, including 
visits to primary care providers, chiropractors, or alterna-
tive therapists.
In multivariable analyses, multiple oral complementary 
medicine use showed specific associations with social/
biomedical factors compared with those using only one 
complementary medicine, including normal body weight, 
higher income levels, with visits to psychologists and 
complementary practitioners and with patient driven/shared 
decision-making preferences (Table 5). In contrast, use of 
only one complementary medicine was significantly associ-
ated with higher education levels and specific morbidities 
(diagnosed arthritis, depressive symptoms).
Complementary medicine use was significantly associ-
ated with a patient-driven preference for decision-making 
in relation to their medical treatment, but not with attitudes 
towards risk-taking or patient satisfaction. In contrast, the 
visits to complementary practitioners were significantly 
associated with attitudes towards risk-taking (Table 4). 
People attending complementary practitioners were signifi-
cantly more likely (P , 0.05) to be classified as risk-takers 
(36%) than either oral complementary medicine users only 
(14%) or nonusers (15%). There were no differences in the 
frequency of general practitioner visits between those who 
also attended complementary practitioners and those who 
did not. In regression analyses, complementary practitioner 
visitors were significantly associated with higher levels of 
education (diploma/trade [OR 1.88, 95% CI: 1.28–2.76], 
bachelor’s degree [OR 1.77, 95% CI: 1.11–2.82]), annual 
household income of at least $80,000 (OR 2.28, 95% CI: 2.28, 
1.26–4.11), female   gender (OR 3.15, 95% CI: 2.19–4.52), 
normal weight (OR 2.38, 95% CI: 1.51–3.76) or overweight 
(OR 2.04, 95% CI: 1.30–3.21), joint pain not diagnosed as 
arthritis (OR 1.68, 95% CI: 1.17–2.41), moderate to severe 
depressive symptoms (OR 2.15, 95% CI: 1.04–4.46), and with 
risk-taking behavior (OR 3.26, 95% CI: 1.80–5.92) or mild-
moderate risk aversion (OR 2.08, 95% CI: 1.26–4.11).
People with mental health conditions were significantly 
more likely to report use of St. John’s wort and vitamin 
supplements (Table 6). Those with diagnosed arthritis were 
significantly more likely to report use of fish oil and glu-
cosamine or shark cartilage, compared with either people 
with undiagnosed joint pain or no joint pain. People visiting 
complementary practitioners (naturopath or osteopath) were 
significantly more likely to be using vitamin supplements, 
herbal preparations, probiotics, and black cohosh, as well as 
fish oil and glucosamine/shark cartilage.
Discussion
Our results confirm that oral complementary medicine use is 
common in the Australian community. We identified subjects 
currently taking oral complementary medicines, and this is 
likely to have resulted in the lower prevalence rate compared 
with previous population studies recording complementary 
medicine use in the previous 12 months.4Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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Table 3 Prevalence of oral complementary medicine and alternative practitioner use in relation to demographic factors, chronic 
disease, and chronic disease risk factors
Factors Oral CM 
% (n)
P Alternative  
practitioner 
% (n)
P
Demographics
sex Male 21.4 (330) ,0.01 4.4 (69) ,0.01
Female 34.2 (553) 10.0 (161)
Age, years ,45 23.7 (363) ,0.01 8.8 (137) ,0.01
45-64 31.7 (315) 7.4 (74)
65+ 32.3 (205) 3.1 (19)
Education secondary school 26.3 (384) 0.15 4.4 (65) ,0.01
diploma, trade qualification 29.5 (340) 8.3 (96)
university degree 29.2 (159) 12.5 (68)
Annual household income ,$20,000 27.8 (166) 0.95 4.1 (24) ,0.01
$20,001-50,000 27.8 (288) 5.5 (58)
$50,001-80,000 28.9 (239) 8.0 (66)
$$80,001 27.2 (151) 13.1 (73)
Employed no 30.7 (319) 0.01 4.2 (43) ,0.01
Yes 26.4 (551) 8.8 (187)
Chronic disease
Diabetes no 27.9 (814) 0.88 7.5 (220) 0.11
Undiagnosed‡ 25.0 (6) 3.6 (7)
Diagnosed† 29.1 (58) 8.3 (2)
Asthma no 27.7 (722) 0.56 7.0 (182) 0.18
Undiagnosed‡ 26.8 (34) 7.9 (10)
Diagnosed† 30.1 (122) 9.5 (38)
Arthritis no 25.7 (630) ,0.01 7.5 (188) 0.09
Yes 36.1 (234) 5.6 (37)
Joint pain/stiffness* no 22.9 (300) ,0.01 6.3 (109) ,0.01
Yes 32.1 (531) 8.5 (121)
Osteoporosis† no 27.4 (824) 0.007 7.4 (224) 0.23
Yes 38.9 (44) 4.4 (5)
Mental health condition† no 26.8 (708) ,0.01 6.5 (173) ,0.01
Yes 33.8 (161) 11.6 (56)
Depressive symptoms (CEs-D) none 26.5 (725) ,0.01 6.9 (192) 0.11
Mild 37.3 (100) 9.3 (25)
Moderate/severe 40.0 (44) 10.9 (12)
CVD† no 27.9 (814) 0.62 7.5 (222) 0.03
Yes 26.3 (54) 3.4 (7)
COPD‡ no 28.1 (837) 0.03 7.3 (218) 0.15
Yes 19.7 (24) 4.1 (6)
Risk factors
smoking status never 28.7 (413) ,0.01 8.4 (120) 0.07
Former 30.6 (330) 6.8 (74)
Current 21.8 (136) 5.6 (35)
BMi‡ normal 31.8 (334) ,0.01 9.2 (96) ,0.01
Overweight  25.3 (299) 7.4 (88)
Obese 27.0 (251) 4.8 (45)
high blood pressure‡ no 27.8 (645) 0.48 8.2 (191) ,0.01
Yes 28.7 (233) 4.5 (37)
high total cholesterol‡ no 28.0 (521) 0.88 7.9 (148) 0.10
Yes 28.2 (362) 6.4 (81)
Exercise level sedentary 29.3 (244) 0.77 3.8 (31) ,0.01
Low 27.4 (291) 7.6 (81)
Moderate 28.8 (213) 9.0 (67)
high 26.8 (63) 14.5 (34)
high-risk alcohol use no 27.6 (791) 0.82 7.6 (216) 0.19
Yes 28.5 (47) 4.8 (8)
Notes: *Pain/stiffness in at least one site including hand, foot, shoulder, back, hip, and knee; †self-reported doctor diagnosis; ‡clinic determined.
Abbreviations: BMi, body mass index; CEs  -D, Center for Epidemiologic studies Depression scale; CM, complementary medicine; COPD, chronic obstructive pulmonary 
disease; CVD, cardiovascular disease.Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
256
Adams et al
Table 4 Oral complementary medicine and alternative practitioner use in relation to health service use in previous 12 months and 
patient factors
Health service providers Oral CM use 
% (n)
P Alternative  
practitioner 
% (n)
P
Primary care provider visits previous year  0 11.6 (31) ,0.01 9.5 (26) 0.30
1–4 28.5 (468) 7.2 (120)
5+ 30.6 (373) 6.8 (84)
Psychologist no 27.6 (846) 0.055 7.2 (224) 0.74
Yes 41.0 (25) 8.3 (5)
Chiropractor no 26.4 (706) ,0.01 5.9 (159) ,0.01
Yes 36.1 (163) 15.3 (70)
Alternative therapist no 26.4 (764) ,0.01
Yes 46.1 (105)
Patient factors
risk aversion risk-takers 26.3 (93) 0.30 11.7 (42) ,0.01
Moderately averse 30.4 (422) 8.7 (122)
highly averse 28.9 (164) 3.9 (22)
Patient satisfaction Very satisfied 32.3 (317) 0.60 7.5 (74) 0.57
Somewhat satisfied  29.4 (156) 9.4 (51)
Somewhat dissatisfied 29.6 (34) 9.6 (11)
Very dissatisfied 35.7 (15) 2.4 (1)
Decision-making preferences Patient decides 30.1 (286) ,0.01 9.2 (88) 0.37
shared decision 33.3 (230) 7.3 (52)
Doctor decides 24.6 (164) 7.0 (47)
Abbreviation: CM, complementary medicine.
Consistent with previous studies, we found that women 
and those with postsecondary education were more likely to 
use oral complementary medicines.2–4,26,27 However, unlike 
other studies, we found that oral complementary medicine 
use was increased in older people (.45 years) compared 
with the younger age group, and numbers of complementary 
medicine used were associated with differing patterns of 
social and morbidity factors. This suggests that oral comple-
mentary medicine users are not homogeneous in terms of 
beliefs, motivations, and needs, and these differences need 
to be examined.28 Awareness of psychosocial factors that 
influence complementary medicine use may help providers 
get a better understanding of the fit between the person and 
the intervention29 and adjust treatment accordingly. People 
taking one oral complementary medicine were more likely to 
have diagnosed arthritis or a mental health condition, and 
attend their general practitioner frequently. It is possible 
that older people are more likely to use oral complementary 
medicines than other types of unconventional therapies, 
such as massage or exercise therapies, but this requires 
further investigation. Previous US work has indicated that 
older age is positively associated with dietary supplements 
but negatively correlated with alternative practitioner use.30 
This may also reflect general practitioners recommending 
certain oral complementary medicines to older people with 
chronic conditions where there is demonstrated or perceived 
efficacy, eg, fish oil or St John’s wort.31 However, the main 
reason cited by participants for complementary medicine use 
was for general health and well-being, rather than for specific 
conditions. This seems to be in accordance with our findings 
that never or reformed smokers rather than current smokers 
were more likely to use oral complementary medicines, and 
that participants with a healthy body mass index were more 
likely to be complementary medicine users.
A strength of our study is the analysis of complementary 
medicine use in relation to patient factors in a representative 
sample, which has been rarely reported. We found a positive 
association of oral complementary medicine use with patient 
decision-making preferences, in contrast with studies reporting 
no association.8,11 Consistent with previous findings,8 comple-
mentary medicine users are not rejecting the more conventional 
health care sector, because general practitioner visits were more 
frequent than among nonusers. Similarly, our findings indicate 
that oral complementary medicine use was not associated with 
dissatisfaction with health system experiences, consistent with 
previous reports in two representative samples from the US,8,10 
or is unrelated to satisfaction with physicians.32
People who saw a complementary practitioner (naturopath 
or osteopath) were more likely to report taking multiple oral 
complementary medicines, and were significantly more likely 
to be risk-takers than oral complementary medicine users, 
who were no different from the nonuser population in this Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
257
Complementary medicine and alternative practitioner use
Table 5 Multivariable logistic regression analyses of factors associated with oral complementary medicine use overall and for patterns 
of oral complementary medicine use
Factors Any oral CM use One oral CM versus none $Two oral CMs versus none
Demographics Or (95% Ci) Or (95% Ci) Or (95% Ci)
Sex
Male 1.00 1.00 1.00
Female 1.75 (1.42–2.15) 1.83 (1.40–2.41)  1.64 (1.25–2.16)
Age, yr
,45 1.00 1.00 1.00
45–64 1.98 (1.55–2.51) 1.91 (1.41–2.60) 2.04 (1.49–2.81)
65+ 2.47 (1.77–3.43) 2.05 (1.33–3.14) 2.90 (1.89–4.45)
Education
secondary 1.00 1.00 1.00
Diploma, trade qualification 1.33 (1.07–1.67) 1.53 (1.15–2.05) 1.15 (0.85–1.54)
University degree 1.23 (0.91–1.67) 1.51 (1.01–2.26) 1.05 (0.71–1.56)
Annual household income
,$20,000 1.00 1.00 1.00
$20,001–50,000 1.53 (1.15–2.05) 1.29 (0.90–1.85) 2.00 (1.34–2.98)
$50,001–80,000 1.78 (1.27–2.49) 1.44 (0.95–2.18) 2.33 (1.46–3.70)
$$80,001 1.64 (1.14–2.37) 1.20 (0.75–1.92) 2.30 (1.39–3.77)
Chronic disease
Diagnosed joint pain*
no 1.00 1.00 1.00
Diagnosed arthritis (OA/rA) 1.41 (1.07–1.85) 1.70 (1.20–2.43) 1.17 (0.82–1.68)
Undiagnosed joint pain 1.26 (1.01–1.59) 1.26 (0.94–1.71) 1.29 (0.95–1.74)
Depressive symptoms CES-D
none 1.00 1.00 1.00
Mild 2.13 (1.52–3.00) 3.03 (2.06–4.45) 1.05 (0.63–1.75)
Moderate/severe 1.78 (1.07–2.97) 2.14 (1.18–3.87) 1.57 (0.77–3.20)
Risk factors
Smoking status
Current 1.00 1.00 1.00
never 1.07 (0.80–1.43) 0.81 (0.57–1.14) 1.65 (1.05–2.59)
Former 1.20 (0.88–1.59) 0.70 (0.49–1.01) 2.39 (1.52–3.77)
BMI†
normal 1.23 (0.96–1.57) 1.06 (0.78–1.48) 1.47 (1.06–2.03)
Overweight  0.80 (0.63–1.02) 0.82 (0.61–1.12) 0.78 (0.56–1.08)
Obese 1.00 1.00 1.00
Health service use in previous 12 months
Primary care provider 
no visits 1.00 1.00 1.00
1–4 3.77 (2.24–6.33) 2.68 (1.42–5.07) 5.96 (2.62–13.5)
5+ 3.62 (2.13–6.17) 2.41 (1.25–4.63) 6.21 (2.70–14.3)
Psychologist
no 1.00 1.00 1.00
Yes 2.89 (1.51–5.53) 1.53 (0.64–3.66) 4.27 (2.00–9.13)
Alternative practitioners‡
no 1.00 1.00 1.00
Yes 2.62 (1.87–3.66) 1.38 (0.85–2.23) 4.59 (3.11–6.78)
Risk aversion
risk-takers 1.35 (0.96–1.91) 1.23 (0.78–1.94) 1.39 (0.89–2.17)
Moderately averse 1.20 (0.94–1.53) 1.33 (0.97–1.81) 1.06 (0.77–1.47)
highly averse 1.00 1.00 1.00
Decision-making preferences
Patient decides 1.38 (1.08–1.77) 1.31 (0.96–1.79) 1.54 (1.11–2.15)
shared decision 1.49 (1.16–1.92) 1.30 (0.94–1.80) 1.80 (1.28–2.53)
Doctor decides 1.00 1.00 1.00
Notes:*Pain/stiffness in at least one site including hand, foot, shoulder, hip, and knee; †clinic determined; ‡includes visits to naturopath, osteopath.
Abbreviations: BMI, body mass index; CES-D, Center for Epidemiologic Studies Depression Scale; CI, confidence interval; CM, complementary medicine; OA, osteoarthritis;   
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Table 6 Complementary medicine used in people with self-reported mental health disorders and joint pain, and in those seeing an 
alternative health practitioner (naturopath or osteopath)
Mental health 
condition
Joint pain CM practitioner
CM (n) no (2639) Yes (477) no (1235) Diagnosed 
arthritis (648)
Joint pain with 
no arthritis diagnosis (1241)
no (2894) Yes (228)
Number CMs
0 (2247) 73.2 (1931) 66.2 (316) 78.1 (964) 63.9 (414) 70.5 (875) 73.6 (2129) 53.7 (123)
1–2 (696) 21.5 (568) 26.8 (128) 17.4 (215) 28.2 (183) 24.2 (300) 22.0 (636) 27.1 (62)
3–4 (142) 4.4 (115) 5.7 (27) 4.0 (49) 6.5 (42) 4.1 (51) 3.7 (107) 14.4 (33)
5+ (31) 0.9 (25) 1.3 (6) 0.6 (7) 1.4 (9) 1.2 (15) 0.7 (21) 4.8 (11)
All vitamins: Multi, B, C, E,  
Coenzyme Q10 (590)
18.2 (481) 22.8* (109) 16.7 (206) 18.4 (119) 21.4* (266) 17.6 (508) 36.0* (82)
Fish oil (205) 6.3 (167) 7.9 (38) 4.7 (58) 13.3* (86) 4.9 (61) 6.2 (180) 11.0* (25)
glucosamine/shark cartilage (175) 5.6 (147) 5.9 (28) 1.8 (22) 13.7* (89) 5.1* (63) 5.1 (149) 11.0* (25)
herbal† (139) 4.4 (117) 4.6 (22) 3.7 (46) 4.9 (32) 5.1 (63) 3.8 (110) 13.2* (30)
Mineral: Mg, Zn (78) 2.3 (61) 3.6 (17) 1.8 (22) 2.6 (17) 3.2 (40) 2.2 (65) 5.7* (13)
st. John’s wort (12) 0.2 (6) 1.3* (6) 0.5 (6) 0.3 (2) 0.3 (4) 0.4 (11) 0.4 (1)
gingko biloba (50) 1.6 (42) 1.7 (8) 1.2 (15) 2.3 (15) 1.7 (21) 1.6 (45) 2.2 (5)
Evening primrose (47) 1.6 (42) 1.0 (5) 1.6 (20) 1.1 (7) 1.6 (20) 1.5 (43) 2.2 (5)
Black cohosh (18) 0.4 (10) 1.7* (8) 0.3 (4) 0.9 (6) 0.7 (9) 0.5 (14) 2.2* (5)
saw Palmetto (13) 0.5 (12) 0.2 (1) 0.3 (4) 0.6 (4) 0.5 (6) 0.4 (12) 0.4 (1)
Probiotics (15) 0.3 (9) 1.3* (6) 0.5 (6) 0.3 (2) 0.6 (7) 0.3 (9) 2.6* (6)
Notes: *P , 0.05 compared with those without the condition; †garlic, celery, ginseng, echinacea, “herbal”, belladonna. 
Abbreviation: CM, complementary medicine.
respect. Previous US survey data suggest that people who 
attend complementary practitioners perceive themselves as 
risk-taking, whereas those that only rely on self-administered 
complementary medicine treatment rate themselves as not 
being different from the general population.7 In a large US 
population study, risk attitude was as strong a predictor of 
visits to complementary medicine providers than the main 
sociodemographic predictors of female gender, higher educa-
tion, or middle-age.7
Our study is limited by its measurement of current com-
plementary medicine use, and we were unable to determine 
how long people had been using complementary medicines 
or whether complementary medicine usage had occurred in 
the recent past. We also do not know how frequently people 
were using complementary medicines. There was also a 
potential bias from survey nonresponse, although response 
rates in our sample were higher than for comparable biomedi-
cal population studies. The strength of this study is the large 
representative population sample with known probability 
of selection, measurements of other known chronic disease 
risk factors, and a low drop-out rate in follow-up, and that 
participants brought in all medications they were taking and 
that usage was clarified at the clinic visits.
Our data suggests the likelihood of a clear split in the 
approach to complementary medicines of primary care 
physicians and other clinicians and that of complementary 
practitioners. General practitioners may be more comfort-
able recommending a limited range of complementary 
medicines where some evidence supports their use (eg, fish 
oil) and where the safety profile is reasonably well known 
and understood. In contrast, other health providers seem 
more likely to suggest other types of complementary 
medicines where evidence of efficacy is less well estab-
lished (eg, probiotics) or the safety of these products is 
more problematic (eg, black cohosh),33,34 to their patients 
who are risk-takers and favor decision-making autonomy. 
Previous work has suggested people use complementary 
medicine “when it is consistent with their world view and 
conventional care is not relieving their symptoms”.32 The 
side effects of conventional medicines in chronic condi-
tions, such as mental health conditions and arthritis, and the 
longevity of treatment, may be prompts for individuals to 
seek alternative treatments which are perceived as “natural” 
and therefore less harmful and with fewer side effects. This 
raises issues of how health care services and regulators 
should respond to the annual expenditure of $1.31 billion 
dollars on complementary medicines in Australia35 that are 
taken mostly for “health and well-being”. MacLennan et al 
have identified that many people incorrectly assume that 
the Australian Therapeutic Goods Administration audits the 
efficacy and safety of complementary medicines4 and that 
complementary medicines are safe.6 The case for more 
detailed consumer product information for complementary 
medicine is given more credence if one considers both the 
variability in health literacy across the population36 and 
the variability in complementary medicine products with 
similar names. The question of what constitutes “informed 
consent” under these circumstances needs greater clarifi-
cation, in terms of risks and benefits by prescribers and 
also at the point of sale. This need to inform consumers 
would also apply to those complementary medicines where 
evidence indicates they are efficacious and appropriate, 
and should be considered as part of an evidence-based 
therapeutic regimen.
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more likely to suggest other types of complementary 
medicines where evidence of efficacy is less well estab-
lished (eg, probiotics) or the safety of these products is 
more problematic (eg, black cohosh),33,34 to their patients 
who are risk-takers and favor decision-making autonomy. 
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medicine “when it is consistent with their world view and 
conventional care is not relieving their symptoms”.32 The 
side effects of conventional medicines in chronic condi-
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longevity of treatment, may be prompts for individuals to 
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and therefore less harmful and with fewer side effects. This 
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have identified that many people incorrectly assume that 
the Australian Therapeutic Goods Administration audits the 
efficacy and safety of complementary medicines4 and that 
complementary medicines are safe.6 The case for more 
detailed consumer product information for complementary 
medicine is given more credence if one considers both the 
variability in health literacy across the population36 and 
the variability in complementary medicine products with 
similar names. The question of what constitutes “informed 
consent” under these circumstances needs greater clarifi-
cation, in terms of risks and benefits by prescribers and 
also at the point of sale. This need to inform consumers 
would also apply to those complementary medicines where 
evidence indicates they are efficacious and appropriate, 
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